MeSH Browser

MeSH Heading: Antitubercular Agents
Tree Number(s): D27.505.954.122.085.255
Unique ID: D000995
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000995
Annotation: consider also MYCOBACTERIUM TUBERCULOSIS /‌drug eff & TUBERCULOSIS /‌drug ther
Scope Note: Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
Entry Term(s): Anti-Tuberculosis Agent; Anti-Tuberculosis Agents; Anti-Tuberculosis Drug; Anti-Tuberculosis Drugs; Antitubercular Agent; Antitubercular Drug; Antitubercular Drugs; Tuberculostatic Agent; Tuberculostatic Agents
Registry Number: 0
See Also: Tuberculosis; Tuberculosis, Multidrug-Resistant
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/01/16

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Chemical Actions and Uses [D27]
- Pharmacologic Actions [D27.505]
  - Therapeutic Uses [D27.505.954]
    - Anti-Infective Agents [D27.505.954.122]
      - Anti-Bacterial Agents [D27.505.954.122.085]
        
        Antitreponemal Agents [D27.505.954.122.085.222]
        
        Antitubercular Agents [D27.505.954.122.085.255]
        
        Antibiotics, Antitubercular [D27.505.954.122.085.255.135]
        
        beta Lactam Antibiotics [D27.505.954.122.085.386]
        
        beta-Lactamase Inhibitors [D27.505.954.122.085.516]
        
        Leprostatic Agents [D27.505.954.122.085.777]

Antitubercular Agents Preferred

Concept UI: M0001515
Registry Number: 0
Scope Note: Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
Terms: Antitubercular Agents Preferred Term
Term UI T003064
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1966); Anti-Tuberculosis Agent
Term UI T000999835
Date11/29/2019
LexicalTag NON
ThesaurusID NLM (2021); Anti-Tuberculosis Drug
Term UI T000999836
Date11/29/2019
LexicalTag NON
ThesaurusID NLM (2021); Tuberculostatic Agents
Term UI T003065
Date12/30/1974
LexicalTag NON
ThesaurusID UNK (19XX); Tuberculostatic Agent
Term UI T000999839
Date11/29/2019
LexicalTag NON
ThesaurusID NLM (2021); Anti-Tuberculosis Drugs
Term UI T000999832
Date11/29/2019
LexicalTag NON
ThesaurusID NLM (2021); Anti-Tuberculosis Agents
Term UI T000999833
Date11/29/2019
LexicalTag NON
ThesaurusID NLM (2021); Antitubercular Drugs
Term UI T003066
Date11/30/1994
LexicalTag NON
ThesaurusID NLM (1996); Antitubercular Agent
Term UI T000999834
Date11/29/2019
LexicalTag NON
ThesaurusID NLM (2021); Antitubercular Drug
Term UI T000999838
Date11/29/2019
LexicalTag NON
ThesaurusID NLM (2021)

Antitubercular Agents MeSH Descriptor Data 2024